IndraLab
Statements
USP41 inhibits cell population proliferation. 1 / 1
|
1
reach
"Interestingly, drug sensitivity analysis with IC50 further suggested that docetaxel, epirubicin and inhibitors of PI3K/AKT/mTOR signaling pathway (afuresertib, buparlisib, ipatasertib and dactolisib) are more beneficial to patients in the low-risk group, whereas tyrosine kinase inhibitors (ibrutinib, lapatinib and sapitinib) may better benefit patients in the high-risk group (
Supplementary Figure S6
).3.9
Sponging ABHD12 and USP41 significantly inhibited the proliferation, invasion and migration of breast cancer cells."